Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Start-Up Licenses Genetics Technology for HIV Diagnostics

David Raiser, left, and Iain MacLeod, founders of Aldatu Biosciences (Aldatu Biosciences)

19 May 2016. A spin-off company from Harvard University is licensing genetics research to develop more powerful tools to detect drug-resistant strains of HIV. Financial details of the agreement between the 2 year-old Aldatu Biosciences Inc. and Harvard were not disclosed.

Aldatu . . . → Read More: Start-Up Licenses Genetics Technology for HIV Diagnostics

Tropical Disease Diagnostics Now on Market

The Carter Center, founded by former U.S. president Jimmy Carter, has been instrumental in eradicating river blindness in Africa. (share.america.gov)

12 April 2016. PATH research institute and medical test developer Standard Diagnostics are making available tests for the tropical diseases onchocerciasis and lymphatic filariasis. The rapid, point-of-care tests are designed to help health authorities . . . → Read More: Tropical Disease Diagnostics Now on Market

Ebola Monitoring System Devised with Genome Sequencing

Ebola genome sequencing lab in Guinea (European Mobile Lab)

3 February 2016. An international team of scientists and engineers designed a mobile system using a hand-held genome sequencing device that provided real-time monitoring of the Ebola outbreak in West Africa in 2015. Researchers led by microbiologists Nicholas Loman and Joshua Quick at University of . . . → Read More: Ebola Monitoring System Devised with Genome Sequencing

Regeneron to Develop Antibody Therapy for Ebola

Scanning electron micrograph shows Ebola virus budding on monkey kidney cells (Defense.gov)

21 September 2015. Regeneron Pharmaceuticals Inc. received a contract from the U.S. Department of Health and Human Services to develop an engineered antibody designed to treat Ebola infections. The initial $17 million contract from HHS’s Biomedical Advanced Research and Development Authority or . . . → Read More: Regeneron to Develop Antibody Therapy for Ebola

Point-of-Care Ebola Test Found Accurate in Field Test

Woman being evaluated at an Ebola clinic in Sierra Leone (Rebecca Rollins, Partners In Health)

26 June 2015. A commercial point-of-care test detecting Ebola virus in the blood of a patient was shown in a field test in Sierra Leone to be as accurate as tests sent to remote labs for analysis. Results of . . . → Read More: Point-of-Care Ebola Test Found Accurate in Field Test

FDA Approves Pediatric HIV Drug Formulation

Scanning electron micrograph of HIV particles infecting a human T cell (NIH.gov)

5 June 2015. The U.S. Food and Drug Administration approved an application for a current HIV drug formulated to better treat infections in infants and young children, especially in limited resource regions. The formulation is a combination of lopinavir and ritonavir in . . . → Read More: FDA Approves Pediatric HIV Drug Formulation

Smartphone Vision App Found Accurate as Clinic Test

Visual acuity test on smartphone (peekvision.org)

29 May 2015. An inexpensive smartphone-based test was found to measure visual acuity as well as the familiar standard eye chart used in clinics. The team that developed the Portable Eye Examination Kit or Peek at the London School of Hygiene and Tropical Medicine and other institutions in . . . → Read More: Smartphone Vision App Found Accurate as Clinic Test

Trial Testing 3-Drug Combo for Drug Resistant TB

Tuberculosis bacteria (DoE.gov)

14 May 2015. A new clinical trial is underway in South Africa testing a regimen of three drugs to treat extensively drug-resistant tuberculosis, a form of the disease that does not respond to normal or even back-up treatments. The trial is sponsored by Global Alliance for TB Drug Development, or TB . . . → Read More: Trial Testing 3-Drug Combo for Drug Resistant TB

Intermediate Trial Shows Ebola Vaccines Safe

Scanning electron micrograph of Ebola virus (National Institute of Allergy and Infectious Diseases)

27 March 2015. An intermediate-stage clinical trial in Liberia testing two new vaccines to prevent Ebola infections, shows the vaccines appear to be safe, allowing for larger-scale assessments. Initial results of the trial were reported yesterday by National Institute of Allergy . . . → Read More: Intermediate Trial Shows Ebola Vaccines Safe

U.S., Canada Authorities OK Biotech Ebola Treatments

Ebola health care workers in Guinea (European Commission-ECHO/USIAD)

23 September 2014. Tekmira Pharmaceuticals Corp. says the U.S. Food and Drug Administration approved the company providing its experimental therapy for people with suspected or confirmed Ebola infections. The Vancouver, British Columbia biotechnology company says approval of its therapy called TKM-Ebola is part of a larger . . . → Read More: U.S., Canada Authorities OK Biotech Ebola Treatments